Recognition of DNA Interstrand Cross-link of Antitumor Cisplatin by HMGB1 Protein-Reference-Cited by-同舟云学术

Recognition of DNA Interstrand Cross-link of Antitumor Cisplatin by HMGB1 Protein

Published:2003-01-17 Issue:5 Volume:42 Page:1234-1244
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Kasparkova Jana¹,Delalande Olivier¹,Stros Michal¹,Elizondo-Riojas Miguel-Angel¹,Vojtiskova Marie¹,Kozelka Jiri¹,Brabec Viktor¹

Affiliation:

1. Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, CZ-61265 Brno, Czech Republic, and Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Universite Rene Descartes, UMR 8601 CNRS, 45 rue des Saints-Peres, F-75006 Paris 06, France

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi026695t

Reference52 articles.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A split β-lactamase sensor for the detection of DNA modification by cisplatin and ruthenium-based chemotherapeutic drugs;Journal of Inorganic Biochemistry;2022-11

2. DNA modification by cisplatin-like Pt(II) complexes containing 1,1′-binaphtyl-2,2′-diamine ligand does not correlate with their antiproliferative activity in cancer cells;Inorganica Chimica Acta;2019-09

3. Effect ofin vivopost-translational modifications of the HMGB1 protein upon binding to platinated DNA: a molecular simulation study;Nucleic Acids Research;2018-11-08

4. Cytotoxic platinum coordination compounds. DNA binding agents;Coordination Chemistry Reviews;2017-11

5. Metallo-Drugs and Their Action;Metals in Medicine;2017-05-06